For: | Tamori A, Kawada N. HLA class II associated with outcomes of hepatitis B and C infections. World J Gastroenterol 2013; 19(33): 5395-5401 [PMID: 24023482 DOI: 10.3748/wjg.v19.i33.5395] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i33/5395.htm |
Number | Citing Articles |
1 |
Mijin Hong, Jaemee Jung, Hyun-Seok Jin, Dahyun Hwang. Genetic polymorphism of HLA-DRA and alcohol consumption affect hepatitis development in the Korean population. Genes & Genomics 2022; 44(9): 1109 doi: 10.1007/s13258-022-01286-1
|
2 |
Mario Frias, Antonio Rivero-Juárez, Pedro López-López, Antonio Rivero. Pharmacogenetics and the Treatment of HIV-/HCV-Coinfected Patients. Pharmacogenomics 2018; 19(12): 979 doi: 10.2217/pgs-2018-0046
|
3 |
H. Y. WANG, F. WANG, M. CHENG, Y. LIU, S. Y. ZHANG. Association of human leukocyte antigen haplotypes with clearance and persistence of hepatitis B virus infection in northeastern China. Epidemiology and Infection 2015; 143(13): 2805 doi: 10.1017/S0950268814003902
|
4 |
Ming Yue, Ke Xu, Meng-Ping Wu, Ya-Ping Han, Peng Huang, Zhi-Hang Peng, Jie Wang, Jing Su, Rong-Bin Yu, Jun Li, Yun Zhang. Human Leukocyte Antigen Class II Alleles Are Associated with Hepatitis C Virus Natural Susceptibility in the Chinese Population. International Journal of Molecular Sciences 2015; 16(8): 16792 doi: 10.3390/ijms160816792
|
5 |
Yinan Yao, Mei Liu, Feng Zang, Ming Yue, Xueshan Xia, Yue Feng, Haozhi Fan, Yun Zhang, Peng Huang, Rongbin Yu. Association betweenhuman leucocyte antigen-DOpolymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study. BMJ Open 2018; 8(4): e019406 doi: 10.1136/bmjopen-2017-019406
|
6 |
Peng Huang, Li Dong, Xiaomei Lu, Yuanyuan Zhang, Hongbo Chen, Jie Wang, Yun Zhang, Jing Su, Rongbin Yu. Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study. BMC Infectious Diseases 2014; 14(1) doi: 10.1186/s12879-014-0716-8
|
7 |
Shay Ben Shachar, Noam Barda, Sigal Manor, Sapir Israeli, Noa Dagan, Shai Carmi, Ran Balicer, Bracha Zisser, Yoram Louzoun. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population. Journal of Clinical Immunology 2021; 41(6): 1154 doi: 10.1007/s10875-021-01071-x
|
8 |
Yin Xu, Peng Huang, Ming Yue, Jing Su, Hongbo Chen, Mingzhu Chen, Jie Wang, Jun Li, Zhihang Peng, Yun Zhang, Rongbin Yu. A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients. Journal of Human Genetics 2016; 61(4): 301 doi: 10.1038/jhg.2015.145
|
9 |
Maciej Janiak, Kamila Caraballo Cortes, Urszula Demkow, Marek Radkowski. Current Concepts in Medical Research and Practice. Advances in Experimental Medicine and Biology 2017; 1039: 45 doi: 10.1007/5584_2017_76
|
10 |
Constantina A. Sarri, Maria Markantoni, Costas Stamatis, Anna Papa, Athanasios Tsakris, Danai Pervanidou, Agoritsa Baka, Constantina Politis, Charalambos Billinis, Christos Hadjichristodoulou, Zissis Mamuris, Ana Paula Arez. Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection. PLOS ONE 2016; 11(11): e0165952 doi: 10.1371/journal.pone.0165952
|
11 |
Amel G. Elsheredy, Abdulrahman H. Almaeen, Amany A. Ghazy, Ghada F. Helaly, Ibrahim Amer, Haneen A. Ghazy, Tamer Haydara. Impact of Interleukin 28B and ICAM-1 Genetic Polymorphisms on Response to Direct Antiviral Treatment Among HCV Infected Patients. Endocrine, Metabolic & Immune Disorders - Drug Targets 2020; 20(8): 1328 doi: 10.2174/1871530320666200505113619
|
12 |
Pietro Lampertico, Mala Maini, George Papatheodoridis. Optimal management of hepatitis B virus infection – EASL Special Conference. Journal of Hepatology 2015; 63(5): 1238 doi: 10.1016/j.jhep.2015.06.026
|
13 |
Anita Kondrashova, Heikki Hyöty. Role of Viruses and Other Microbes in the Pathogenesis of Type 1 Diabetes. International Reviews of Immunology 2014; 33(4): 284 doi: 10.3109/08830185.2014.889130
|
14 |
Ayako Iida-Ueno, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada. Hepatitis B virus infection and alcohol consumption. World Journal of Gastroenterology 2017; 23(15): 2651-2659 doi: 10.3748/wjg.v23.i15.2651
|
15 |
Xiaodong Xu, Ming Yue, Longfeng Jiang, Xiaozhao Deng, Yongxiang Zhang, Yun Zhang, Danyan Zhu, Wen Xiao, Zhenxian Zhou, Wenjuan Yao, Jing Kong, Xiaojie Yu, Juan Wei. Genetic Variants in Human Leukocyte Antigen-DP Influence Both Hepatitis C Virus Persistence and Hepatitis C Virus F Protein Generation in the Chinese Han Population. International Journal of Molecular Sciences 2014; 15(6): 9826 doi: 10.3390/ijms15069826
|
16 |
Pratima Anand, Srijan Singh, Robert L Schelonka, Atnafu Mekonnen Tekleab, Amit Upadhyay. Hepatitis B Infections in Neonates. Newborn 2022; 1(4): 368 doi: 10.5005/jp-journals-11002-0049
|
17 |
Maria Lönnrot, Kristian Lynch, Helena Elding Larsson, Åke Lernmark, Marian Rewers, William Hagopian, Jin-Xiong She, Olli Simell, Anette-G Ziegler, Beena Akolkar, Jeffrey Krischer, Heikki Hyöty. A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY. BMC Pediatrics 2015; 15(1) doi: 10.1186/s12887-015-0333-8
|
18 |
Amira A. Shahin, Olfat G. Shaker, Hanan E. Darweesh, Mohammed El Sayed, Basma M. Ali. Does human leukocyte antigen influence the risk of development and type of vasculitis in Egyptian patients with chronic hepatitis C virus infection?. The Egyptian Rheumatologist 2016; 38(4): 307 doi: 10.1016/j.ejr.2016.06.004
|
19 |
Maria Ascierto, Federica Bozzano, Davide Bedognetti, Francesco Marras, Cathy Schechterly, Kentaro Matsuura, Antonino Picciotto, Simona Marenco, Yingdong Zhao, Valeria DeGiorgi, Michele Sommariva, Lorenzo Moretta, Ena Wang, Harvey J Alter, Francesco M Marincola, Andrea De Maria. Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus. Journal of Translational Medicine 2015; 13(1): 77 doi: 10.1186/s12967-015-0428-x
|
20 |
Wonderful Tatenda Choga, Motswedi Anderson, Edward Zumbika, Bonolo B. Phinius, Tshepiso Mbangiwa, Lynnette N. Bhebhe, Kabo Baruti, Peter Opiyo Kimathi, Kaelo K. Seatla, Rosemary M. Musonda, Trevor Graham Bell, Sikhulile Moyo, Jason T. Blackard, Simani Gaseitsiwe. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses 2020; 12(7): 731 doi: 10.3390/v12070731
|